var data={"title":"Anesthetic management for enhanced recovery after major surgery (ERAS) in adults","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Anesthetic management for enhanced recovery after major surgery (ERAS) in adults</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/contributors\" class=\"contributor contributor_credentials\">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/contributors\" class=\"contributor contributor_credentials\">Roberta Hines, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 24, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1906261156\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multimodal, multidisciplinary fast-track surgery, also known as enhanced recovery after surgery (ERAS) or enhanced recovery pathways (ERPs), can hasten functional recovery after various types of surgical procedures [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/1\" class=\"abstract_t\">1</a>]. <span class=\"nowrap\">ERAS/ERP</span> protocols involve improvements in several components of the preoperative, intraoperative, and postoperative periods (<a href=\"image.htm?imageKey=ANEST%2F115922\" class=\"graphic graphic_table graphicRef115922 \">table 1</a>). </p><p>This topic discusses management of components of anesthetic care for enhanced recovery after major surgical procedures [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/2\" class=\"abstract_t\">2</a>]. Surgical aspects of ERAS protocols for colorectal and gynecological surgery are discussed in other topics. (See <a href=\"topic.htm?path=enhanced-recovery-after-colorectal-surgery\" class=\"medical medical_review\">&quot;Enhanced recovery after colorectal surgery&quot;</a> and <a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation\" class=\"medical medical_review\">&quot;Enhanced recovery after gynecologic surgery: Components and implementation&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H911660903\"><span class=\"h1\">DEFINITION OF ERAS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Enhanced recovery after surgery (ERAS) refers to evidence-based protocols that standardize care to minimize surgical stress response and postoperative pain, reduce complications, improve outcomes, decrease hospital length of stay, and expedite recovery following elective procedures. (See <a href=\"topic.htm?path=enhanced-recovery-after-colorectal-surgery#H117217498\" class=\"medical medical_review\">&quot;Enhanced recovery after colorectal surgery&quot;, section on 'Elements of ERAS'</a> and <a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation#H3448018794\" class=\"medical medical_review\">&quot;Enhanced recovery after gynecologic surgery: Components and implementation&quot;, section on 'Definition'</a>.)</p><p>Patients undergoing many types of elective major surgical procedures with a planned overnight stay are candidates for participation in an ERAS protocol. Although specialty-specific ERAS pathways can broadly apply to the majority of patients undergoing colorectal, gynecologic, or other major surgical procedures, such pathways should always be individualized if medically indicated. (See <a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation#H4067969844\" class=\"medical medical_review\">&quot;Enhanced recovery after gynecologic surgery: Components and implementation&quot;, section on 'Candidates'</a>.)</p><p class=\"headingAnchor\" id=\"H3553091597\"><span class=\"h1\">PREOPERATIVE CONSIDERATIONS</span></p><p class=\"headingAnchor\" id=\"H2361859820\"><span class=\"h2\">Preanesthesia consultation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specific goals during the preanesthesia consultation are to:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Identify comorbidities and opportunities to optimize the patient's preoperative condition, which may improve postoperative outcomes. (See <a href=\"topic.htm?path=preanesthesia-evaluation-for-noncardiac-surgery\" class=\"medical medical_review\">&quot;Preanesthesia evaluation for noncardiac surgery&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Emphasize minimizing the fasting period and maintaining hydration during the fasting period. Specific instructions include (see <a href=\"topic.htm?path=enhanced-recovery-after-colorectal-surgery#H11858731\" class=\"medical medical_review\">&quot;Enhanced recovery after colorectal surgery&quot;, section on 'Fasting guidelines'</a>):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We advise patients to hydrate during the fasting period, including consuming two glasses of water prior to going to bed and two glasses of water before traveling to the hospital on the morning of surgery. There is no evidence that restriction of the volume of clear liquids is beneficial [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/3\" class=\"abstract_t\">3</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We do not use complex carbohydrate loading; however, patients are given an option to consume a simple carbohydrate drink (eg, apple juice or Gatorade) if they wish. This drink must be consumed at least two hours prior to surgery, typically at home (rather than consuming two glasses of water).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Educate the patient and family to set expectations regarding the patient's own role in the recovery process, reduce patient anxiety, and increase satisfaction. In particular, preoperative planning for pain management emphasizes realistic expectations regarding postoperative pain relief [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H2165741456\" class=\"local\">'Postoperative anesthetic management'</a> below.) </p><p/><p class=\"headingAnchor\" id=\"H3232169428\"><span class=\"h2\">Premedication</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Medications administered in the immediate preoperative period include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> (paracetamol) 1.5 g, administered at least two hours preoperatively if there are no contraindications.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral cyclooxygenase (COX)-2 specific inhibitor (eg, <a href=\"topic.htm?path=celecoxib-drug-information\" class=\"drug drug_general\">celecoxib</a> 400 mg) at least two hours preoperatively, if no contraindications.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral <a href=\"topic.htm?path=gabapentin-drug-information\" class=\"drug drug_general\">gabapentin</a> 300 to 600 mg, administered at least two hours preoperatively. We avoid gabapentin in patients &gt;65 years old and those with sleep-disordered breathing (eg, obstructive sleep apnea) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Concerns regarding use of gabapentinoids include sedation and ventilatory depression, particularly if these agents are combined with opioids [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thromboprophylaxis with subcutaneous heparin 5000 units, administered 30 to 60 minutes before surgery. Prophylaxis also includes placement of bilateral sequential compression devices prior to induction of anesthesia. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We avoid routine administration of benzodiazepine premedication. Many anesthesiologists administer a small intravenous (IV) dose of a benzodiazepine, typically <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a> 1 to 2 mg, just before transfer of the patient from the holding area to the operating room. Perceived benefits include anxiolysis, sedation, amnesia, and improved patient satisfaction [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/7\" class=\"abstract_t\">7</a>], although these benefits are controversial [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/8\" class=\"abstract_t\">8</a>]. Potential adverse effects of benzodiazepines include postoperative amnesia, drowsiness, and cognitive dysfunction [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/9\" class=\"abstract_t\">9</a>], increased incidence of pharyngeal dysfunction and discoordinated breathing and swallowing [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/10,11\" class=\"abstract_t\">10,11</a>], and occasional unpredictable paradoxical reactions (eg, irritability, aggressiveness, delirium) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/12,13\" class=\"abstract_t\">12,13</a>]. In one large randomized trial in 1062 adults &lt;70 years of age, premedication with a long-acting benzodiazepine (<a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a>) was associated with modestly prolonged time to tracheal extubation, delayed cognitive recovery, and no improvement in self-reported postoperative patient experiences [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/14\" class=\"abstract_t\">14</a>].</p><p/><p class=\"headingAnchor\" id=\"H2526748191\"><span class=\"h1\">INTRAOPERATIVE ANESTHETIC MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anesthetic techniques are selected to provide optimal operating conditions with consistent and rapid recovery of cognition and physical functions such as ambulation and oral intake, ideally with minimal or no adverse effects. The anesthesiologist also manages other aspects of intraoperative care such as fluid administration and ventilation that can affect both immediate and long-term postoperative outcomes [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"headingAnchor\" id=\"H272906940\"><span class=\"h2\">Induction of anesthesia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Major surgical procedures (eg, major gastrointestinal and gynecological procedures) are typically performed under general anesthesia, including minimally invasive surgery such as laparoscopic approaches that may minimize surgical stress responses [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=anesthesia-for-laparoscopic-and-abdominal-robotic-surgery-in-adults\" class=\"medical medical_review\">&quot;Anesthesia for laparoscopic and abdominal robotic surgery in adults&quot;</a> and <a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation\" class=\"medical medical_review\">&quot;Enhanced recovery after gynecologic surgery: Components and implementation&quot;</a>.) &#160;</p><p>A typical induction sequence in an adult patient includes intravenous (IV) <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> approximately 1 <span class=\"nowrap\">mcg/kg</span> ideal body weight (IBW), given three to five minutes prior to <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> 20 to 30 mg, followed by <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> 1 to 1.5 <span class=\"nowrap\">mg/kg</span> to achieve loss of eyelash reflex <span class=\"nowrap\">and/or</span> response to verbal command. In addition, a nondepolarizing neuromuscular blocking agent (NMBA) such as <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a> 0.6 to 1 <span class=\"nowrap\">mg/kg</span> IBW may be administered to provide muscle relaxation that facilitates laryngoscopy and insertion of an endotracheal tube (ETT). Selection and dosing of induction agents (sedative-hypnotic, opioid) may be modified based on patient characteristics such as hemodynamic instability, aspiration risk, or a potentially difficult airway. (See <a href=\"topic.htm?path=general-anesthesia-induction\" class=\"medical medical_review\">&quot;General anesthesia: Induction&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intravenous induction agents </strong>&mdash; <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">Propofol</a> remains the IV drug of choice for induction of anesthesia due to its unique recovery profile, antiemetic properties, and euphoria on emergence. Commonly used adjuvants include <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> to minimize the pain associated with propofol injection and an opioid (usually <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a>) to blunt the sympathetic responses to laryngoscopy and tracheal intubation as well as reduce the propofol dose required to achieve loss of consciousness [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/17,18\" class=\"abstract_t\">17,18</a>]. (See <a href=\"topic.htm?path=general-anesthesia-induction#H295889145\" class=\"medical medical_review\">&quot;General anesthesia: Induction&quot;, section on 'Intravenous anesthetic induction'</a>.)</p><p/><p class=\"bulletIndent1\"><a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">Propofol</a> and opioid dosing should be judicious during induction of anesthesia. Large bolus doses of these agents may result in significant post-induction hypotension and need for vasopressor support [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/19,20\" class=\"abstract_t\">19,20</a>]. (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents#H4070595924\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;, section on 'Dosing considerations'</a> and <a href=\"topic.htm?path=perioperative-uses-of-intravenous-opioids-in-adults#H153801862\" class=\"medical medical_review\">&quot;Perioperative uses of intravenous opioids in adults&quot;, section on 'Dosing considerations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Neuromuscular blocking agents </strong>&mdash; An intermediate-acting non-depolarizing NMBA such as <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a> is typically selected for the induction sequence. In patients with a high risk for pulmonary aspiration or a potentially difficult airway, we select <a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a> if there are no contraindications. Further details regarding selection of a muscle relaxant for use during induction are available in separate topics: &#160;</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=general-anesthesia-induction#H2800567302\" class=\"medical medical_review\">&quot;General anesthesia: Induction&quot;, section on 'Neuromuscular blocking agents'</a>.)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H2476711246\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Endotracheal intubation'</a>.)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H996697223\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Adverse effects of succinylcholine'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1043323230\"><span class=\"h2\">Antibiotic prophylaxis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Routine IV antibiotic prophylaxis is administered 30 to 60 minutes before the surgical incision as standard of care. To achieve this timing goal, we typically administer prophylactic antibiotics immediately after induction of general anesthesia. The choice and dose of the antibiotics are discussed separately. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-prevention-of-surgical-site-infection-in-adults\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for prevention of surgical site infection in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1012725307\"><span class=\"h2\">Maintenance of anesthesia</span></p><p class=\"headingAnchor\" id=\"H2082250100\"><span class=\"h3\">Inhalation versus total intravenous anesthesia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Maintenance of general anesthesia can be accomplished using either inhalation anesthesia or total intravenous anesthesia (TIVA) techniques. It is prudent to use short-acting agents administered at the lowest possible dose in patients participating in enhanced recovery after surgery (ERAS) protocols, since residual effects of inhalation anesthetics and IV hypnotic-sedatives, opioids, and muscle relaxants can delay recovery and have adverse effects. Goals for emergence from general anesthesia include planning a rapid clearheaded awakening, with adequate analgesia. (See <a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence#H1762635082\" class=\"medical medical_review\">&quot;General anesthesia: Maintenance and emergence&quot;, section on 'Inhalation anesthesia'</a> and <a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence#H7869294\" class=\"medical medical_review\">&quot;General anesthesia: Maintenance and emergence&quot;, section on 'Total intravenous anesthesia'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Inhalation anesthesia</strong> &mdash; For most patients, we prefer an inhalation-based technique with a potent volatile agent (<a href=\"topic.htm?path=desflurane-drug-information\" class=\"drug drug_general\">desflurane</a> or <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>) and <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> (N<sub>2</sub>O) 50 percent in oxygen to achieve an age-adjusted minimum alveolar concentration (MAC) value of approximately 1.0. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H2769569626\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'MAC and MAC-awake values for inhalation agents'</a>.)</p><p/><p class=\"bulletIndent1\">To maintain adequate anesthetic depth, alarms are set to detect low end-tidal anesthetic concentrations (eg, age-adjusted MAC &lt;0.7) <span class=\"nowrap\">and/or</span> neuromonitoring is employed (eg, bispectral [BIS] index) to reduce the incidence of awareness [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/21\" class=\"abstract_t\">21</a>] (see <a href=\"topic.htm?path=awareness-with-recall-following-general-anesthesia#H14\" class=\"medical medical_review\">&quot;Awareness with recall following general anesthesia&quot;, section on 'End-tidal anesthetic concentration'</a> and <a href=\"topic.htm?path=awareness-with-recall-following-general-anesthesia#H15\" class=\"medical medical_review\">&quot;Awareness with recall following general anesthesia&quot;, section on 'Neuromonitoring'</a>). However, we avoid deep anesthesia. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H4120616033\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Continuum of effect: sedation to general anesthesia'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Advantages of the potent volatile inhalation anesthetics include (see <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;</a>):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Some degree of muscle relaxation, allowing minimized dosing of NMBA. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H443815897\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Skeletal and smooth muscle relaxation'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Ease of titration. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery#H1913196443\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;, section on 'Factors affecting inhalation anesthetic delivery'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Rapid recovery, particularly with use of the short-acting inhalation anesthetics (<a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a> or <a href=\"topic.htm?path=desflurane-drug-information\" class=\"drug drug_general\">desflurane</a>) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/22\" class=\"abstract_t\">22</a>]. Clinical differences between desflurane and sevoflurane appear to be small, although several studies have reported more rapid emergence with desflurane [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/23,24\" class=\"abstract_t\">23,24</a>]. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H670378431\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Sevoflurane'</a> and <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H1665285148\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Desflurane'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Total intravenous anesthesia</strong> &mdash; In some cases, a TIVA technique is selected. The major advantage of a propofol-based TIVA technique is a reduced incidence of postoperative nausea and vomiting (PONV) compared with inhalation anesthesia, particularly in patients at high risk for this complication [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/25\" class=\"abstract_t\">25</a>]. However, one meta-analysis found no overall difference in risk of PONV when TIVA was compared with an inhalation technique if at least one prophylactic antiemetic agent was administered [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=postoperative-nausea-and-vomiting#H1226576483\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;, section on 'Prevention'</a>.)</p><p/><p class=\"bulletIndent1\">A typical TIVA technique includes infusion of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> 75 to 150 <span class=\"nowrap\">mcg/kg/minute,</span> with titration based on neuromonitoring to avoid awareness. A <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a> infusion is typically selected for a TIVA technique for ERAS procedures, with titration to achieve hemodynamic stability. (See <a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence#H7869294\" class=\"medical medical_review\">&quot;General anesthesia: Maintenance and emergence&quot;, section on 'Total intravenous anesthesia'</a> and <a href=\"topic.htm?path=awareness-with-recall-following-general-anesthesia#H15\" class=\"medical medical_review\">&quot;Awareness with recall following general anesthesia&quot;, section on 'Neuromonitoring'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2877574991\"><span class=\"h3\">Opioids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We avoid high doses of opioids, which may increase risk for postoperative opioid-related adverse events such as nausea, vomiting, sedation, bladder dysfunction, and respiratory depression [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/27\" class=\"abstract_t\">27</a>], and may increase potential for acute tolerance, delayed hyperalgesia, and paradoxical increases in postoperative pain and opioid dosing requirements [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/28\" class=\"abstract_t\">28</a>]. (See <a href=\"topic.htm?path=perioperative-uses-of-intravenous-opioids-in-adults#H4025963507\" class=\"medical medical_review\">&quot;Perioperative uses of intravenous opioids in adults&quot;, section on 'Prevention and management of adverse effects'</a>.)</p><p>Small bolus doses of an opioid (eg, <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> 25 to 50 mcg) may be administered during the intraoperative period if indicated (eg, when increased heart rate <span class=\"nowrap\">and/or</span> blood pressure are noted). However, intraoperative tachycardia and hypertension often occur due to causes other than pain. For example, during laparoscopic surgical procedures, factors such as increased intra-abdominal pressure, absorption of carbon dioxide (CO<sub>2</sub>), and effects of surgical positioning may lead to tachycardia <span class=\"nowrap\">and/or</span> hypertension. Treatment of such hyperdynamic responses with an opioid (eg, fentanyl) is not appropriate. Once fentanyl requirements have exceeded 1 <span class=\"nowrap\">mcg/kg</span> per hour, we typically treat hypertension <span class=\"nowrap\">(and/or</span> tachycardia) with vasoactive agents such as beta blockers or vasodilators rather than with additional doses of an opioid. (See <a href=\"topic.htm?path=anesthesia-for-adult-patients-with-hypertension#H2370645806\" class=\"medical medical_review\">&quot;Anesthesia for adult patients with hypertension&quot;, section on 'Prevention and treatment of intraoperative hypertension'</a>.)</p><p class=\"headingAnchor\" id=\"H2313057756\"><span class=\"h3\">Neuromuscular blocking agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An NMBA is often administered to facilitate surgical exposure during laparoscopic or other surgical procedures [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/29,30\" class=\"abstract_t\">29,30</a>]. We avoid profound muscle paralysis by using a peripheral nerve stimulator to aim for a moderate level of neuromuscular blockade during laparoscopic procedures (eg, a train-of-four [TOF] count of 2 to 3). It is unknown whether deeper levels of neuromuscular blockade during laparoscopic procedures lead to fewer intraoperative complications or improved quality of recovery [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/29,31\" class=\"abstract_t\">29,31</a>]. However, for robotic surgery, we maintain a deeper level of neuromuscular blockade until the robotic device is undocked (eg, a TOF count of 0 to 1). (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H1994682241\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Facilitation of surgery'</a> and <a href=\"topic.htm?path=monitoring-neuromuscular-blockade#H1932544448\" class=\"medical medical_review\">&quot;Monitoring neuromuscular blockade&quot;, section on 'Train-of-four'</a>.)</p><p>Maintenance of deep neuromuscular blockade results in use of high doses of NMBAs and increased risk of residual muscle weakness at the end of the procedure (defined as a TOF ratio &lt;0.9), which may lead to postoperative respiratory complications [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/32-35\" class=\"abstract_t\">32-35</a>] (see <a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu#H3859137208\" class=\"medical medical_review\">&quot;Respiratory problems in the post-anesthesia care unit (PACU)&quot;, section on 'Neuromuscular blocking agents'</a>). Approaches to reduce the incidence of residual paralysis include avoiding long-acting NMBAs, using the smallest dose of an NMBA that provides optimal surgical conditions, and reversing any residual neuromuscular blockade near the end of the procedure. Dosing of <a href=\"topic.htm?path=neostigmine-drug-information\" class=\"drug drug_general\">neostigmine</a> or <a href=\"topic.htm?path=sugammadex-drug-information\" class=\"drug drug_general\">sugammadex</a> for reversal is based on the degree of residual neuromuscular blockade at the time the reversal agent is administered [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/25,36-38\" class=\"abstract_t\">25,36-38</a>]. Details regarding timing and adequacy of reversal are found in separate topics:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence#H4220917875\" class=\"medical medical_review\">&quot;General anesthesia: Maintenance and emergence&quot;, section on 'Reverse effects of neuromuscular blocking agents'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H154268994\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Reversal of neuromuscular block'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3528502899\"><span class=\"h3\">Nitrous oxide</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We routinely use <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> (N<sub>2</sub>O) for ERAS procedures. The amnestic and analgesic properties of N<sub>2</sub>O reduce the requirements of other anesthetic and adjuvant agents [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/39\" class=\"abstract_t\">39</a>]. Furthermore, N<sub>2</sub>O facilitates both uptake and removal of the potent volatile inhalation anesthetics via its second gas effect, thereby allowing rapid emergence from anesthesia [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/40,41\" class=\"abstract_t\">40,41</a>]. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H3010090094\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Advantages'</a> and <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery#H3037530422\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;, section on 'Second gas effect'</a>.)</p><p>Despite these beneficial effects, some clinicians avoid N<sub>2</sub>O due to concerns regarding increased risk of PONV, as well as possible bowel distention during colorectal procedures due to expansion of closed spaces (see <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H1206995058\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Disadvantages and adverse effects'</a>). However, the emetic effects of N<sub>2</sub>O can be mitigated with use of prophylactic antiemetics [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/42-44\" class=\"abstract_t\">42-44</a>]. Also, several studies have noted that surgeons do not recognize a difference between conditions in patients receiving N<sub>2</sub>O during colorectal surgery compared with patients not receiving N<sub>2</sub>O [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/45-47\" class=\"abstract_t\">45-47</a>]. </p><p class=\"headingAnchor\" id=\"H2309437483\"><span class=\"h2\">Mechanical ventilation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intraoperative lung protective mechanical ventilation reduces postoperative pulmonary complications, length of hospital stay, and mortality after major surgery. (See <a href=\"topic.htm?path=ventilator-induced-lung-injury\" class=\"medical medical_review\">&quot;Ventilator-induced lung injury&quot;</a> and <a href=\"topic.htm?path=physiologic-and-pathophysiologic-consequences-of-mechanical-ventilation\" class=\"medical medical_review\">&quot;Physiologic and pathophysiologic consequences of mechanical ventilation&quot;</a>.)</p><p> Optimal ventilatory parameters include (see <a href=\"topic.htm?path=mechanical-ventilation-during-anesthesia-in-adults#H3186383247\" class=\"medical medical_review\">&quot;Mechanical ventilation during anesthesia in adults&quot;, section on 'Lung protective ventilation during anesthesia'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low tidal volumes (ie, 6 to 8 <span class=\"nowrap\">mL/kg</span> IBW)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initial positive end-expiratory pressure (PEEP) 5 cm H<sub>2</sub>O (10 cm H<sub>2</sub>O during laparoscopic procedures)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plateau pressures &le;16 mmHg</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fraction of inspired oxygen (FiO<sub>2</sub>) 0.5</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initial respiratory rate of 8 <span class=\"nowrap\">breaths/minute,</span> subsequently adjusted to maintain end-tidal CO<sub>2</sub> levels at approximately 40 mmHg (rather than traditional values of 30 to 35 mmHg) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/48\" class=\"abstract_t\">48</a>]. These higher CO<sub>2</sub> levels improve hemodynamics and tissue perfusion [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/49,50\" class=\"abstract_t\">49,50</a>]. (See <a href=\"topic.htm?path=mechanical-ventilation-during-anesthesia-in-adults#H333660329\" class=\"medical medical_review\">&quot;Mechanical ventilation during anesthesia in adults&quot;, section on 'Goal end tidal carbon dioxide'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Performance of recruitment maneuvers only when indicated to improve oxygenation or in specific circumstances (eg, after disconnection from the ventilator for suctioning). (See <a href=\"topic.htm?path=mechanical-ventilation-during-anesthesia-in-adults#H2892527554\" class=\"medical medical_review\">&quot;Mechanical ventilation during anesthesia in adults&quot;, section on 'Recruitment maneuvers'</a>.)</p><p/><p>During laparoscopic procedures peak airway pressures <span class=\"nowrap\">and/or</span> desaturation may necessitate temporary modifications in these ventilator settings. (See <a href=\"topic.htm?path=anesthesia-for-laparoscopic-and-abdominal-robotic-surgery-in-adults#H10521908\" class=\"medical medical_review\">&quot;Anesthesia for laparoscopic and abdominal robotic surgery in adults&quot;, section on 'Mechanical ventilation'</a>.)</p><p>During emergence, we maintain minute ventilation in an effort to eliminate inhalation anesthetic agents and facilitate rapid emergence. Although some clinicians reduce the respiratory rate near the end of the procedure in an effort to increase end-tidal CO<sub>2</sub> levels to simulate respiration, this reduction of respiratory rate and minute ventilation can delay removal of inhalation anesthetics, thereby delaying emergence. (See <a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence#H283253221\" class=\"medical medical_review\">&quot;General anesthesia: Maintenance and emergence&quot;, section on 'Emergence from general anesthesia'</a>.)</p><p class=\"headingAnchor\" id=\"H244926194\"><span class=\"h2\">Fluid management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intraoperative fluid management is aimed at restoring and maintaining euvolemia. (See <a href=\"topic.htm?path=intraoperative-fluid-management#H254311346\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Our approach to fluid management'</a>.) </p><p>We typically use a restrictive (zero-balance) fluid therapy approach that minimizes fluid administration during colorectal or gynecologic surgical procedures. We administer a balanced electrolyte solution (eg, Ringer's lactate) 1 to 3 <span class=\"nowrap\">mL/kg/hour</span>. We do not &quot;preload&quot; fluid prior to neuraxial block or induction of general anesthesia, or replace urine output, calculated insensible losses, or nonanatomic &quot;third space&quot; losses. (See <a href=\"topic.htm?path=intraoperative-fluid-management#H2410959413\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Restrictive (zero-balance) strategy'</a>.)</p><p>In selected patients undergoing major surgery, this approach is supplemented by goal-directed fluid therapy [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/51\" class=\"abstract_t\">51</a>], with administration of fluid boluses (typically 200 to 250 mL) based on dynamic hemodynamic parameters such as manual estimation or automated calculation of variations in systolic blood pressure or pulse pressure in the intra-arterial waveform tracing, or variations in stroke volume. (See <a href=\"topic.htm?path=intraoperative-fluid-management#H626508222\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Goal-directed fluid therapy'</a> and <a href=\"topic.htm?path=intraoperative-fluid-management#H254311286\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Dynamic hemodynamic parameters'</a>.)</p><p>In one randomized multicenter trial of 150 patients undergoing elective colorectal surgery, equivalent postoperative outcomes were noted with a zero-balance (restrictive) approach compared with a goal-directed approach to fluid therapy [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/52\" class=\"abstract_t\">52</a>]. If preoperative dehydration is avoided and early postoperative alimentation is emphasized as part of an ERAS protocol, then goal-directed fluid therapy may be unnecessary because of the low risk of perioperative fluid imbalance [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/53-55\" class=\"abstract_t\">53-55</a>]. A 2016 meta-analysis of randomized controlled trials of patients undergoing elective major abdominal surgery (2099 patients; 23 studies) noted no benefit when goal-directed fluid therapy was used within the setting of an ERAS protocol, compared with a fixed-volume regimen [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/56\" class=\"abstract_t\">56</a>].</p><p>Either a restrictive or a goal-directed approach is superior to traditional approaches employing liberal fluid administration, as described separately. (See <a href=\"topic.htm?path=intraoperative-fluid-management#H3041008465\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Avoid traditional liberal or fixed-volume approaches'</a>.)</p><p class=\"headingAnchor\" id=\"H497236349\"><span class=\"h2\">Temperature control</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Core body temperature is routinely monitored at the esophageal or nasopharyngeal site, and warming devices are employed to maintain normothermia (temperature &ge;35.5&deg;C) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/57-60\" class=\"abstract_t\">57-60</a>]. These include upper- and lower-body forced-air warming devices and blankets, insulation water mattresses, and devices for warming all IV fluids. (See <a href=\"topic.htm?path=perioperative-temperature-management#H87204780\" class=\"medical medical_review\">&quot;Perioperative temperature management&quot;, section on 'Intraoperative hypothermia'</a>.) </p><p>Hypothermia is avoided because of potential complications (eg, shivering, coagulopathy, prolonged duration of stay in the post-anesthesia care unit, surgical site infection, adverse cardiac events) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/60\" class=\"abstract_t\">60</a>]. Postoperative hypothermia is most likely to occur when procedures are longer than two hours, and in older patients or those who have comorbid illness or little body fat [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/60\" class=\"abstract_t\">60</a>]. (See <a href=\"topic.htm?path=perioperative-temperature-management#H1029603522\" class=\"medical medical_review\">&quot;Perioperative temperature management&quot;, section on 'Postoperative temperature derangements'</a>.)</p><p class=\"headingAnchor\" id=\"H1125347342\"><span class=\"h2\">Glycemic control</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Perioperative glycemic control is initiated in the preoperative period, including appropriate advice to diabetic patients regarding hypoglycemic drugs and insulin administration. Perioperative blood glucose levels are monitored and maintained between 140 and 200 <span class=\"nowrap\">mg/dL</span> (7.8 to 11 <span class=\"nowrap\">mmol/L)</span> in both diabetic and nondiabetic patients throughout the perioperative period. More aggressive control is avoided as this incurs risk of hypoglycemia and associated postoperative complications. (See <a href=\"topic.htm?path=perioperative-management-of-blood-glucose-in-adults-with-diabetes-mellitus\" class=\"medical medical_review\">&quot;Perioperative management of blood glucose in adults with diabetes mellitus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4078456404\"><span class=\"h2\">Antiemetic prophylaxis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We routinely use multimodal antiemetic prophylaxis in all patients participating in ERAS protocols to facilitate early recovery [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/61\" class=\"abstract_t\">61</a>]. Although selective risk-based approaches for antiemetic therapy have been proposed, compliance with these strategies may be poor [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/62\" class=\"abstract_t\">62</a>]. (See <a href=\"topic.htm?path=postoperative-nausea-and-vomiting#H1157266081\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;, section on 'Risk stratification'</a>.)</p><p>We typically use a combination of IV <a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">dexamethasone</a> 8 mg administered after induction of anesthesia and a 5-HT<sub>3</sub> antagonist such as IV <a href=\"topic.htm?path=ondansetron-drug-information\" class=\"drug drug_general\">ondansetron</a> 4 mg administered at the end of surgical procedure. For patients at very high risk of PONV (eg, history of motion sickness, history of previous PONV, known high opioid requirements for pain relief), we administer an additional antiemetic agent such as preoperative transdermal <a href=\"topic.htm?path=scopolamine-hyoscine-drug-information\" class=\"drug drug_general\">scopolamine</a> or intraoperative IV <a href=\"topic.htm?path=haloperidol-drug-information\" class=\"drug drug_general\">haloperidol</a> 0.5 to 1 mg administered after induction of anesthesia. Use of more than three antiemetics has not been shown to confer additional clinical benefit [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/63\" class=\"abstract_t\">63</a>]. In addition, a TIVA technique may be considered in a high-risk patient. (See <a href=\"topic.htm?path=postoperative-nausea-and-vomiting#H144014180\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;, section on 'Antiemetics'</a>.)</p><p class=\"headingAnchor\" id=\"H909429008\"><span class=\"h2\">Pain prophylaxis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multimodal pain management is patient-specific and procedure-specific, with the goal of minimizing pain during rest and also during mobilization and physical therapy. The following agents and techniques are often part of multimodal strategies selected to balance analgesic efficacy with overall side effects (see <a href=\"topic.htm?path=management-of-acute-perioperative-pain#H447933291\" class=\"medical medical_review\">&quot;Management of acute perioperative pain&quot;, section on 'Strategy for perioperative pain control'</a>): </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nonopioid analgesics </strong>&mdash; We typically administer IV <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> 1 g (if not previously administered in the preoperative period) and IV <a href=\"topic.htm?path=ketorolac-drug-information\" class=\"drug drug_general\">ketorolac</a> 15 to 30 mg (if no contraindications) near the end of the surgical procedure. </p><p/><p class=\"bulletIndent1\">Multimodal strategies commonly include combinations of oral <span class=\"nowrap\">and/or</span> IV non-opioid analgesics. For example, <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> (paracetamol) combined with a nonsteroidal antiinflammatory agent (NSAID) or a COX-2 specific inhibitor provides superior analgesia compared with either drug alone [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64\" class=\"abstract_t\">64</a>]. These agents are administered in the preoperative or intraoperative period, and are then continued in the postoperative period with regular scheduled dosing [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64\" class=\"abstract_t\">64</a>]. NSAIDs are avoided until completion of surgery in the intraoperative period due to antiplatelet effects that may increase risk of perioperative bleeding. However, COX-2 specific inhibitors spare the COX-1 enzyme and have no antiplatelet effects; thus, they may be administered in the preoperative period. </p><p/><p class=\"bulletIndent1\">It is unknown whether NSAIDs increase risk of anastomotic leak or cancer recurrence after major gastrointestinal surgery for cancer [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/65\" class=\"abstract_t\">65</a>]. (See <a href=\"topic.htm?path=management-of-anastomotic-complications-of-colorectal-surgery#H2710307\" class=\"medical medical_review\">&quot;Management of anastomotic complications of colorectal surgery&quot;, section on 'Controversial, inconclusive, or negative'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Local or regional anesthetic techniques</strong> &mdash; A local or regional anesthetic technique is often employed as a primary component of the multimodal analgesic regimen. (See <a href=\"topic.htm?path=management-of-acute-perioperative-pain#H447933291\" class=\"medical medical_review\">&quot;Management of acute perioperative pain&quot;, section on 'Strategy for perioperative pain control'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Local infiltration or surgical field block </strong>&mdash; Infiltration of the surgical wound with local anesthetic provides excellent analgesia that outlasts the duration of action of the drug; therefore, this technique is used whenever possible [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/66\" class=\"abstract_t\">66</a>]. </p><p/><p class=\"bulletIndent2\">An alternative is a surgical field block such as the transversus abdominis plane (TAP) block, which provides excellent pain relief after laparoscopic or open lower (below the umbilicus) abdominal surgical procedures [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/67\" class=\"abstract_t\">67</a>]. Analgesic efficacy of a TAP block is similar to that of surgical wound infiltration after open total abdominal hysterectomy [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/68\" class=\"abstract_t\">68</a>]. However, a TAP block is unlikely to be superior to surgical site infiltration after laparoscopic procedures with a small incision [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/69\" class=\"abstract_t\">69</a>]. (See <a href=\"topic.htm?path=nerve-blocks-of-the-scalp-neck-and-trunk-techniques#H520467453\" class=\"medical medical_review\">&quot;Nerve blocks of the scalp, neck, and trunk: Techniques&quot;, section on 'Transversus abdominis plane block'</a>.)</p><p/><p class=\"bulletIndent2\">Use of a long-acting liposomal local anesthetic (eg, <a href=\"topic.htm?path=liposomal-bupivacaine-drug-information\" class=\"drug drug_general\">liposomal bupivacaine</a>) has been associated with reduced opioid use, a shorter length of stay (mean three versus four days), and lower overall cost in one nonrandomized study [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/70\" class=\"abstract_t\">70</a>]. For cost reasons, some clinicians do not use liposomal bupivacaine for local infiltration, but may use it for transversus abdominis plane (TAP) blocks [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/71\" class=\"abstract_t\">71</a>]. </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Neuraxial analgesia </strong>&mdash; We do not use epidural analgesia after laparoscopic surgery because of potential delays in ambulation and hospital discharge (due to postural hypotension and presence of catheters), without additional benefit for pain control [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64,69,72-74\" class=\"abstract_t\">64,69,72-74</a>].</p><p/><p class=\"bulletIndent2\">Although epidural analgesia provides excellent pain relief after major open abdominal or other lower body surgical procedures, it is unnecessary after less invasive surgical approaches [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64\" class=\"abstract_t\">64</a>]. Rarely, thoracic epidural analgesia is used for an open procedure with a long midline incision (eg, from the xiphoid process to the pubis), together with a TAP block to supplement the subumbilical portion of the incision. We avoid administration of an intrathecal opioid such as <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">morphine</a> for any ERAS procedure due to high risk for adverse effects (eg, nausea, vomiting, pruritus, urinary retention, respiratory depression) and minimal additional benefit since alternative analgesic techniques provide similar pain relief [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64\" class=\"abstract_t\">64</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Fixed dose of a long-acting opioid </strong>&mdash; In most open surgical procedures, a precalculated dose of a long-acting opioid is administered approximately 20 minutes prior to expected time of extubation (typically when the surgeon starts closing the abdomen). We use <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">morphine</a> 0.05 <span class=\"nowrap\">mg/kg</span> IBW or <a href=\"topic.htm?path=hydromorphone-drug-information\" class=\"drug drug_general\">hydromorphone</a> 5 to 10 <span class=\"nowrap\">mcg/kg</span> IBW after a laparoscopic procedure, or morphine 0.1 <span class=\"nowrap\">mg/kg</span> IBW or hydromorphone 10 to 15 <span class=\"nowrap\">mcg/kg</span> IBW after an open procedure. This approach does not delay awakening or tracheal extubation [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/75\" class=\"abstract_t\">75</a>]. Some clinicians attempt to titrate a long-acting opioid to produce a respiratory rate of approximately 12 to 15 breaths per minute during emergence from anesthesia, but potential residual effects of anesthetic agents and NMBAs make this approach challenging.</p><p/><p class=\"bulletIndent1\">Long-acting opioids are always used sparingly due to opioid-related adverse effects that delay recovery and return to activities of daily living (eg, delayed emergence from anesthesia, postoperative respiratory depression, delirium, PONV, urinary retention necessitating bladder catheterization, pruritus, development of acute tolerance or hyperalgesia) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/27\" class=\"abstract_t\">27</a>]. (See <a href=\"topic.htm?path=perioperative-uses-of-intravenous-opioids-in-adults#H153801862\" class=\"medical medical_review\">&quot;Perioperative uses of intravenous opioids in adults&quot;, section on 'Dosing considerations'</a> and <a href=\"topic.htm?path=perioperative-uses-of-intravenous-opioids-in-adults#H4025963507\" class=\"medical medical_review\">&quot;Perioperative uses of intravenous opioids in adults&quot;, section on 'Prevention and management of adverse effects'</a>.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Adjunct agents </strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">Dexamethasone</a> &mdash; We often administer dexamethasone 8 to 10 mg for its analgesic and antiemetic prophylaxis [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/76-81\" class=\"abstract_t\">76-81</a>] Although there are concerns of increase in blood glucose and surgical site infection, large observational studies did not report these adverse effects. Thus, the dexamethasone 8 to 10 mg should be administered routinely [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/78,81\" class=\"abstract_t\">78,81</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">Ketamine</a> &mdash; We do not routinely use intraoperative ketamine to achieve postoperative analgesia. Although low-dose (25 to 50 mg) ketamine administered after induction of anesthesia has been reported to improve postoperative pain relief [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/82\" class=\"abstract_t\">82</a>], there are concerns regarding adverse effects including psychotomimetic effects (eg, hallucinations, nightmares, vivid dreams) during and shortly after emergence from anesthesia [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64,83\" class=\"abstract_t\">64,83</a>]. (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents#H2269465\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;, section on 'Ketamine'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2165741456\"><span class=\"h1\">POSTOPERATIVE ANESTHETIC MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postoperative goals in enhanced recovery after surgery (ERAS) protocols include prevention and relief of pain and postoperative nausea or vomiting (PONV), as well as facilitation of early nutrition and mobilization [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64,84\" class=\"abstract_t\">64,84</a>].</p><p class=\"headingAnchor\" id=\"H1830785956\"><span class=\"h2\">Management of pain</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While the patient is in the post-anesthesia care unit (PACU), postoperative pain is treated with small bolus doses of either intravenous (IV) <a href=\"topic.htm?path=hydromorphone-drug-information\" class=\"drug drug_general\">hydromorphone</a> 0.1 mg (up to 1 mg) or IV <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">morphine</a> 1 to 2 mg doses (up to 10 mg). </p><p>We use scheduled doses of oral <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> 1 g four times per day and an oral nonsteroidal antiinflammatory drug [NSAID] (eg, <a href=\"topic.htm?path=meloxicam-drug-information\" class=\"drug drug_general\">meloxicam</a> 15 mg once per day) or oral cyclooxygenase [COX]-2 specific inhibitor (eg, <a href=\"topic.htm?path=celecoxib-drug-information\" class=\"drug drug_general\">celecoxib</a> 200 mg twice per day) [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/72\" class=\"abstract_t\">72</a>]. In patients who do not yet tolerate oral liquids, acetaminophen, <a href=\"topic.htm?path=ibuprofen-drug-information\" class=\"drug drug_general\">ibuprofen</a>, and <a href=\"topic.htm?path=ketorolac-drug-information\" class=\"drug drug_general\">ketorolac</a> are each available in an intravenous (IV) formulation.</p><p>For major open surgical procedures, we also use oral <a href=\"topic.htm?path=gabapentin-drug-information\" class=\"drug drug_general\">gabapentin</a> 300 mg three times per day. </p><p>We administer oral <a href=\"topic.htm?path=oxycodone-drug-information\" class=\"drug drug_general\">oxycodone</a> for breakthrough pain. If a patient is unable to take oxycodone, we use <a href=\"topic.htm?path=tramadol-drug-information\" class=\"drug drug_general\">tramadol</a> 50 mg four times per day as needed. Only rarely do we use IV opioids, typically administered via patient-controlled analgesia (PCA). </p><p class=\"headingAnchor\" id=\"H4243497461\"><span class=\"h2\">Management of nausea and vomiting</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients requiring postoperative rescue antiemetic therapy to treat PONV, we typically administer IV <a href=\"topic.htm?path=promethazine-drug-information\" class=\"drug drug_general\">promethazine</a> 0.625 mg, <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=ondansetron-drug-information\" class=\"drug drug_general\">ondansetron</a> 4 mg (no earlier than four hours after the intraoperative dose), <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=dimenhydrinate-drug-information\" class=\"drug drug_general\">dimenhydrinate</a> 1 <span class=\"nowrap\">mg/kg</span>.</p><p class=\"headingAnchor\" id=\"H3965677478\"><span class=\"h1\">OUTCOMES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data from observational studies and randomized trials in patients undergoing colorectal surgery show that enhanced recovery after surgery (ERAS) protocols are associated with reduced hospital length of stay and morbidity, reduced postoperative pain, faster recovery, comparable or reduced readmission rate, and cost savings compared with traditional care. These outcomes are discussed in a separate topic. (See <a href=\"topic.htm?path=enhanced-recovery-after-colorectal-surgery#H117217535\" class=\"medical medical_review\">&quot;Enhanced recovery after colorectal surgery&quot;, section on 'Outcomes'</a>.)</p><p>Similarly, studies in various types of gynecologic surgery have noted that ERAS protocols are associated with decreased pain, length of stay, use of nursing time, and overall costs, thereby improving patient satisfaction and quality of life. (See <a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation#H1255857432\" class=\"medical medical_review\">&quot;Enhanced recovery after gynecologic surgery: Components and implementation&quot;, section on 'Outcomes'</a>.)</p><p>These long-term postoperative outcomes are influenced by anesthesia-related management throughout the perioperative period, including [<a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/15\" class=\"abstract_t\">15</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preoperative management (eg, optimization of comorbid conditions, preoperative hydration during the fasting period, planning for minimal postoperative pain, nausea, or vomiting). (See <a href=\"#H3553091597\" class=\"local\">'Preoperative considerations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intraoperative management (eg, use of short-acting anesthetic and neuromuscular blocking agents [NMBAs] in small doses, avoidance of fluid overload, maintenance of normothermia and adequate glycemic control, pain prophylaxis, administration of antiemetics, complete reversal of residual effects of NMBAs). (See <a href=\"#H2526748191\" class=\"local\">'Intraoperative anesthetic management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Management in the immediate postoperative period (eg, treatment of pain and nausea or vomiting). (See <a href=\"#H2165741456\" class=\"local\">'Postoperative anesthetic management'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H200683127\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preoperative management to facilitate enhanced recovery after surgery (ERAS) emphasizes (see <a href=\"#H3553091597\" class=\"local\">'Preoperative considerations'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Identifying comorbidities and opportunities to optimize the patient's preoperative condition.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Minimizing the fasting period and maintaining hydration during the fasting period. Specific instructions include:</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Advice to patients to hydrate during the fasting period, including consuming two glasses of water prior to going to bed and two glasses of water before traveling to the hospital on the morning of surgery.</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Patients are given an option to consume a simple carbohydrate drink (eg, apple juice or Gatorade) rather than two glasses of water at least two hours prior to surgery. We do not use complex carbohydrate loading.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Preoperative patient and family education. In particular, preoperative planning for pain management emphasizes realistic expectations regarding postoperative pain relief.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preoperative medications for ERAS protocols may include oral <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> (paracetamol) 1.5 g and oral <a href=\"topic.htm?path=gabapentin-drug-information\" class=\"drug drug_general\">gabapentin</a> 300 to 600 mg administered at least two hours before surgery. Also, subcutaneous heparin 5000 units is administered 30 to 60 minutes before surgery for thromboprophylaxis. We avoid routine administration of benzodiazepine premedication. (See <a href=\"#H3232169428\" class=\"local\">'Premedication'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A typical anesthetic induction sequence includes intravenous (IV) <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> approximately 1 <span class=\"nowrap\">mcg/kg</span> ideal body weight (IBW), given three to five minutes prior to <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> 20 to 30 mg, followed by <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> 1 to 1.5 <span class=\"nowrap\">mg/kg</span> to achieve loss of eyelash reflex <span class=\"nowrap\">and/or</span> response to verbal command. In addition, a nondepolarizing neuromuscular blocking agent (NMBA) such as <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a> 0.6 to 1 <span class=\"nowrap\">mg/kg</span> IBW may be administered to facilitate laryngoscopy and endotracheal intubation. (See <a href=\"#H272906940\" class=\"local\">'Induction of anesthesia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We prefer an inhalation-based technique with a potent volatile agent (<a href=\"topic.htm?path=desflurane-drug-information\" class=\"drug drug_general\">desflurane</a> or <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>) and <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> (N<sub>2</sub>O) 50 percent in oxygen to achieve approximately 1.0 minimum alveolar concentration (MAC). We use short-acting agents administered at the lowest possible dose, and we avoid deep anesthesia. (See <a href=\"#H2082250100\" class=\"local\">'Inhalation versus total intravenous anesthesia'</a> above and <a href=\"#H3528502899\" class=\"local\">'Nitrous oxide'</a> above.):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We avoid high doses of opioids. Small bolus doses of an opioid (eg, <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> 25 to 50 mcg) may be administered as needed during the intraoperative period, but we typically limit the dose (eg, &le;1 <span class=\"nowrap\">mcg/kg</span> per hour fentanyl). (See <a href=\"#H2877574991\" class=\"local\">'Opioids'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>An NMBA is often administered to facilitate surgical exposure, but we avoid profound muscle paralysis by using a peripheral nerve stimulator. (See <a href=\"#H2313057756\" class=\"local\">'Neuromuscular blocking agents'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Optimal ventilatory parameters include low tidal volumes (ie, 6 to 8 <span class=\"nowrap\">mL/kg</span> IBW), initial positive end-expiratory pressure (PEEP) 5 cm H<sub>2</sub>O (10 cm H<sub>2</sub>O during laparoscopic procedures), plateau pressures &le;16 mmHg, fraction of inspired oxygen (FiO<sub>2</sub>) 0.5, and an initial respiratory rate of 8 <span class=\"nowrap\">breaths/minute,</span> subsequently adjusted to maintain end-tidal CO<sub>2</sub> levels approximately 40 mmHg. (See <a href=\"#H2309437483\" class=\"local\">'Mechanical ventilation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We typically use a restrictive (zero-balance) fluid therapy approach to minimize fluid administration, with administration of a balanced electrolyte solutions (eg, Ringer's lactate) at 1 to 3 <span class=\"nowrap\">mL/kg</span> per hour. We do not &quot;preload&quot; fluid prior to induction of general anesthesia, or replace urine output, calculated insensible losses, or nonanatomic &quot;third space&quot; losses. In selected patients undergoing major surgery, this approach is supplemented by goal-directed fluid therapy with administration of fluid boluses (typically 200 to 250 mL) based on dynamic hemodynamic parameters. (See <a href=\"#H244926194\" class=\"local\">'Fluid management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Core body temperature is routinely monitored and warming devices are employed to maintain normothermia (temperature &ge;35.5&deg;C). (See <a href=\"#H497236349\" class=\"local\">'Temperature control'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Perioperative blood glucose levels are monitored and maintained between 140 and 200 <span class=\"nowrap\">mg/dL</span> (7.8 to 11 <span class=\"nowrap\">mmol/L)</span> in both diabetic and nondiabetic patients. (See <a href=\"#H1125347342\" class=\"local\">'Glycemic control'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antiemetic prophylaxis includes IV <a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">dexamethasone</a> 8 mg after induction of anesthesia and <a href=\"topic.htm?path=ondansetron-drug-information\" class=\"drug drug_general\">ondansetron</a> 4 mg at the end of surgery. For patients at very high risk of postoperative nausea and vomiting (PONV), we add a transdermal <a href=\"topic.htm?path=scopolamine-hyoscine-drug-information\" class=\"drug drug_general\">scopolamine</a> patch or IV <a href=\"topic.htm?path=haloperidol-drug-information\" class=\"drug drug_general\">haloperidol</a> 0.5 to 1 mg. Postoperative rescue treatment for PONV includes IV <a href=\"topic.htm?path=promethazine-drug-information\" class=\"drug drug_general\">promethazine</a> 0.625 mg, <span class=\"nowrap\">and/or</span> ondansetron 4 mg (no earlier than four hours after the intraoperative dose), <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=dimenhydrinate-drug-information\" class=\"drug drug_general\">dimenhydrinate</a> 1 <span class=\"nowrap\">mg/kg</span>. (See <a href=\"#H4078456404\" class=\"local\">'Antiemetic prophylaxis'</a> above and <a href=\"#H4243497461\" class=\"local\">'Management of nausea and vomiting'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We employ multimodal pain prophylaxis that includes (see <a href=\"#H909429008\" class=\"local\">'Pain prophylaxis'</a> above and <a href=\"#H1830785956\" class=\"local\">'Management of pain'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Administration of IV <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> 1 g (if not administered preoperatively), an IV nonsteroidal antiinflammatory drug (NSAID) such as <a href=\"topic.htm?path=ketorolac-drug-information\" class=\"drug drug_general\">ketorolac</a> 15 to 30 mg (if there are no contraindications), and IV <a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">dexamethasone</a> 8 to 10 mg.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Local or regional techniques, such as surgical site infiltration for laparoscopic procedures or transversus abdominis plane (TAP block) for open procedures. However, we avoid epidural analgesia for laparoscopic surgery because of potential delays in ambulation and hospital discharge without additional benefits for pain control.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A precalculated dose of a long-acting opioid that is administered approximately 20 minutes prior to expected time of extubation (eg, <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">morphine</a> 0.05 <span class=\"nowrap\">mg/kg</span> IBW or <a href=\"topic.htm?path=hydromorphone-drug-information\" class=\"drug drug_general\">hydromorphone</a> 5 to 10 <span class=\"nowrap\">mcg/kg</span> IBW for laparoscopic surgical procedures [or morphine 0.1 <span class=\"nowrap\">mg/kg</span> IBW or hydromorphone 10 to 15 <span class=\"nowrap\">mcg/kg</span> IBW for open procedures]).</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/1\" class=\"nounderline abstract_t\">Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008; 248:189.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/2\" class=\"nounderline abstract_t\">Feldheiser A, Aziz O, Baldini G, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 2016; 60:289.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/3\" class=\"nounderline abstract_t\">Brady M, Kinn S, Stuart P. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev 2003; :CD004423.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/4\" class=\"nounderline abstract_t\">Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17:131.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/5\" class=\"nounderline abstract_t\">Fabritius ML, Geisler A, Petersen PL, et al. Gabapentin for post-operative pain management - a systematic review with meta-analyses and trial sequential analyses. Acta Anaesthesiol Scand 2016; 60:1188.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/6\" class=\"nounderline abstract_t\">Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN. Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression. Anesth Analg 2017; 125:141.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/7\" class=\"nounderline abstract_t\">Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth 2004; 16:177.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/8\" class=\"nounderline abstract_t\">Bucx MJ, Krijtenburg P, Kox M. Preoperative use of anxiolytic-sedative agents; are we on the right track? J Clin Anesth 2016; 33:135.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/9\" class=\"nounderline abstract_t\">Rogers JF, Morrison AL, Nafziger AN, et al. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics. Clin Pharmacol Ther 2002; 72:711.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/10\" class=\"nounderline abstract_t\">H&aring;rdemark Cedborg AI, Sundman E, Bod&eacute;n K, et al. Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults. Anesthesiology 2015; 122:1253.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/11\" class=\"nounderline abstract_t\">Petroianni A, Ceccarelli D, Conti V, Terzano C. Aspiration pneumonia. Pathophysiological aspects, prevention and management. A review. Panminerva Med 2006; 48:231.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/12\" class=\"nounderline abstract_t\">Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004; 24:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/13\" class=\"nounderline abstract_t\">Lepous&eacute; C, Lautner CA, Liu L, et al. Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth 2006; 96:747.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/14\" class=\"nounderline abstract_t\">Maurice-Szamburski A, Auquier P, Viarre-Oreal V, et al. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA 2015; 313:916.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/15\" class=\"nounderline abstract_t\">Sessler DI. Long-term consequences of anesthetic management. Anesthesiology 2009; 111:1.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/16\" class=\"nounderline abstract_t\">Scott MJ, Baldini G, Fearon KC, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations. Acta Anaesthesiol Scand 2015; 59:1212.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/17\" class=\"nounderline abstract_t\">Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database Syst Rev 2013; :CD004087.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/18\" class=\"nounderline abstract_t\">Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81:820.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/19\" class=\"nounderline abstract_t\">Salmasi V, Maheshwari K, Yang D, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology 2017; 126:47.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/20\" class=\"nounderline abstract_t\">S&uuml;dfeld S, Brechnitz S, Wagner JY, et al. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth 2017; 119:57.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/21\" class=\"nounderline abstract_t\">Shanks AM, Avidan MS, Kheterpal S, et al. Alerting thresholds for the prevention of intraoperative awareness with explicit recall: a secondary analysis of the Michigan Awareness Control Study. Eur J Anaesthesiol 2015; 32:346.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/22\" class=\"nounderline abstract_t\">Miller TE, Gan TJ. Total intravenous anesthesia and anesthetic outcomes. J Cardiothorac Vasc Anesth 2015; 29 Suppl 1:S11.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/23\" class=\"nounderline abstract_t\">Jakobsson J. Desflurane: a clinical update of a third-generation inhaled anaesthetic. Acta Anaesthesiol Scand 2012; 56:420.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/24\" class=\"nounderline abstract_t\">Dexter F, Bayman EO, Epstein RH. Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane. Anesth Analg 2010; 110:570.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/25\" class=\"nounderline abstract_t\">Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth 2010; 105:558.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/26\" class=\"nounderline abstract_t\">Schaefer MS, Kranke P, Weibel S, et al. Total intravenous anaesthesia versus single-drug pharmacological antiemetic prophylaxis in adults: A systematic review and meta-analysis. Eur J Anaesthesiol 2016; 33:750.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/27\" class=\"nounderline abstract_t\">de Boer HD, Detriche O, Forget P. Opioid related side effects: postoperative ileus, urinary retention, nausea and vomiting and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/28\" class=\"nounderline abstract_t\">Mauermann E, Filitz J, Dolder P, et al. Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial. Anesthesiology 2016; 124:453.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/29\" class=\"nounderline abstract_t\">Madsen MV, Staehr-Rye AK, Claudius C, G&auml;tke MR. Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably. Acta Anaesthesiol Scand 2016; 60:710.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/30\" class=\"nounderline abstract_t\">Bruintjes MH, van Helden EV, Braat AE, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth 2017; 118:834.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/31\" class=\"nounderline abstract_t\">Kopman AF, Naguib M. Is deep neuromuscular block beneficial in laparoscopic surgery? No, probably not. Acta Anaesthesiol Scand 2016; 60:717.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/32\" class=\"nounderline abstract_t\">Brull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology 2017; 126:173.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/33\" class=\"nounderline abstract_t\">Bulka CM, Terekhov MA, Martin BJ, et al. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Anesthesiology 2016; 125:647.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/34\" class=\"nounderline abstract_t\">Stewart PA, Liang SS, Li QS, et al. The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit: A Prospective Study of Prevalence, Predictors, and Outcomes. Anesth Analg 2016; 123:859.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/35\" class=\"nounderline abstract_t\">Bronsert MR, Henderson WG, Monk TG, et al. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival. Anesth Analg 2017; 124:1476.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/36\" class=\"nounderline abstract_t\">Fuchs-Buder T, Meistelman C, Alla F, et al. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology 2010; 112:34.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/37\" class=\"nounderline abstract_t\">Kaufhold N, Schaller SJ, St&auml;uble CG, et al. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)&dagger;,. Br J Anaesth 2016; 116:233.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/38\" class=\"nounderline abstract_t\">Herbstreit F, Zigrahn D, Ochterbeck C, et al. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113:1280.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/39\" class=\"nounderline abstract_t\">de Vasconcellos K, Sneyd JR. Nitrous oxide: are we still in equipoise? A qualitative review of current controversies. Br J Anaesth 2013; 111:877.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/40\" class=\"nounderline abstract_t\">Peyton PJ, Chao I, Weinberg L, et al. Nitrous oxide diffusion and the second gas effect on emergence from anesthesia. Anesthesiology 2011; 114:596.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/41\" class=\"nounderline abstract_t\">Mraovic B, Simurina T, Gan TJ. Nitrous oxide added at the end of isoflurane anesthesia hastens early recovery without increasing the risk for postoperative nausea and vomiting: a randomized clinical trial. Can J Anaesth 2018; 65:162.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/42\" class=\"nounderline abstract_t\">Fern&aacute;ndez-Guisasola J, G&oacute;mez-Arnau JI, Cabrera Y, del Valle SG. Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis. Anaesthesia 2010; 65:379.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/43\" class=\"nounderline abstract_t\">Myles PS, Chan MT, Kasza J, et al. Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial. Anesthesiology 2016; 124:1032.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/44\" class=\"nounderline abstract_t\">Joshi GP, Pennant JH, Kehlet H. Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia (ENIGMA) Studies: The Tale of Two Large Pragmatic Randomized Controlled Trials. Anesth Analg 2017; 124:2077.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/45\" class=\"nounderline abstract_t\">Taylor E, Feinstein R, White PF, Soper N. Anesthesia for laparoscopic cholecystectomy. Is nitrous oxide contraindicated? Anesthesiology 1992; 76:541.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/46\" class=\"nounderline abstract_t\">Krogh B, J&oslash;rn Jensen P, Henneberg SW, et al. Nitrous oxide does not influence operating conditions or postoperative course in colonic surgery. Br J Anaesth 1994; 72:55.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/47\" class=\"nounderline abstract_t\">Brodsky JB, Lemmens HJ, Collins JS, et al. Nitrous oxide and laparoscopic bariatric surgery. Obes Surg 2005; 15:494.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/48\" class=\"nounderline abstract_t\">Joshi GP. The role of carbon dioxide in facilitating emergence from inhalation anesthesia: then &amp; now. Anesth Analg 2012; 114:933.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/49\" class=\"nounderline abstract_t\">Hager H, Reddy D, Mandadi G, et al. Hypercapnia improves tissue oxygenation in morbidly obese surgical patients. Anesth Analg 2006; 103:677.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/50\" class=\"nounderline abstract_t\">Fleischmann E, Herbst F, Kugener A, et al. Mild hypercapnia increases subcutaneous and colonic oxygen tension in patients given 80% inspired oxygen during abdominal surgery. Anesthesiology 2006; 104:944.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/51\" class=\"nounderline abstract_t\">Makaryus R, Miller TE, Gan TJ. Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth 2018; 120:376.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/52\" class=\"nounderline abstract_t\">Brandstrup B, Svendsen PE, Rasmussen M, et al. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? Br J Anaesth 2012; 109:191.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/53\" class=\"nounderline abstract_t\">Joshi GP, Kehlet H. CON: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol? Anesth Analg 2016; 122:1261.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/54\" class=\"nounderline abstract_t\">Minto G, Scott MJ, Miller TE. Monitoring needs and goal-directed fluid therapy within an enhanced recovery program. Anesthesiol Clin 2015; 33:35.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/55\" class=\"nounderline abstract_t\">G&oacute;mez-Izquierdo JC, Feldman LS, Carli F, Baldini G. Meta-analysis of the effect of goal-directed therapy on bowel function after abdominal surgery. Br J Surg 2015; 102:577.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/56\" class=\"nounderline abstract_t\">Rollins KE, Lobo DN. Intraoperative Goal-directed Fluid Therapy in Elective Major Abdominal Surgery: A Meta-analysis of Randomized Controlled Trials. Ann Surg 2016; 263:465.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/57\" class=\"nounderline abstract_t\">John M, Ford J, Harper M. Peri-operative warming devices: performance and clinical application. Anaesthesia 2014; 69:623.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/58\" class=\"nounderline abstract_t\">Perl T, Br&auml;uer A, Quintel M. Prevention of perioperative hypothermia with forced-air warming systems and upper-body blankets. Surg Technol Int 2006; 15:19.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/59\" class=\"nounderline abstract_t\">Madrid E, Urr&uacute;tia G, Roqu&eacute; i Figuls M, et al. Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults. Cochrane Database Syst Rev 2016; 4:CD009016.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/60\" class=\"nounderline abstract_t\">Sessler DI. Perioperative thermoregulation and heat balance. Lancet 2016; 387:2655.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/61\" class=\"nounderline abstract_t\">Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118:85.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/62\" class=\"nounderline abstract_t\">Kappen TH, Vergouwe Y, van Wolfswinkel L, et al. Impact of adding therapeutic recommendations to risk assessments from a prediction model for postoperative nausea and vomiting. Br J Anaesth 2015; 114:252.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/63\" class=\"nounderline abstract_t\">Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012; 109:742.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/64\" class=\"nounderline abstract_t\">Joshi GP, Schug SA, Kehlet H. Procedure-specific pain management and outcome strategies. Best Pract Res Clin Anaesthesiol 2014; 28:191.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/65\" class=\"nounderline abstract_t\">Cata JP, Guerra CE, Chang GJ, et al. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth 2017; 119:750.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/66\" class=\"nounderline abstract_t\">Joshi GP, Janis JE, Haas EM, et al. Surgical Site Infiltration for Abdominal Surgery: A Novel Neuroanatomical-based Approach. Plast Reconstr Surg Glob Open 2016; 4:e1181.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/67\" class=\"nounderline abstract_t\">De Oliveira GS Jr, Castro-Alves LJ, Nader A, et al. Transversus abdominis plane block to ameliorate postoperative pain outcomes after laparoscopic surgery: a meta-analysis of randomized controlled trials. Anesth Analg 2014; 118:454.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/68\" class=\"nounderline abstract_t\">Gasanova I, Alexander J, Ogunnaike B, et al. Transversus Abdominis Plane Block Versus Surgical Site Infiltration for Pain Management After Open Total Abdominal Hysterectomy. Anesth Analg 2015; 121:1383.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/69\" class=\"nounderline abstract_t\">Kehlet H, Joshi GP. Systematic Reviews and Meta-Analyses of Randomized Controlled Trials on Perioperative Outcomes: An Urgent Need for Critical Reappraisal. Anesth Analg 2015; 121:1104.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/70\" class=\"nounderline abstract_t\">Keller DS, Pedraza R, Tahilramani RN, et al. Impact of long-acting local anesthesia on clinical and financial outcomes in laparoscopic colorectal surgery. Am J Surg 2017; 214:53.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/71\" class=\"nounderline abstract_t\">Kim AJ, Yong RJ, Urman RD. The Role of Transversus Abdominis Plane Blocks in Enhanced Recovery After Surgery Pathways for Open and Laparoscopic Colorectal Surgery. J Laparoendosc Adv Surg Tech A 2017; 27:909.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/72\" class=\"nounderline abstract_t\">Joshi GP, Bonnet F, Kehlet H, PROSPECT collaboration. Evidence-based postoperative pain management after laparoscopic colorectal surgery. Colorectal Dis 2013; 15:146.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/73\" class=\"nounderline abstract_t\">Levy BF, Scott MJ, Fawcett W, et al. Randomized clinical trial of epidural, spinal or patient-controlled analgesia for patients undergoing laparoscopic colorectal surgery. Br J Surg 2011; 98:1068.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/74\" class=\"nounderline abstract_t\">Hanna MH, Jafari MD, Jafari F, et al. Randomized Clinical Trial of Epidural Compared with Conventional Analgesia after Minimally Invasive Colorectal Surgery. J Am Coll Surg 2017; 225:622.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/75\" class=\"nounderline abstract_t\">Aubrun F, Amour J, Rosenthal D, et al. Effects of a loading dose of morphine before i.v. morphine titration for postoperative pain relief: a randomized, double-blind, placebo-control study. Br J Anaesth 2007; 98:124.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/76\" class=\"nounderline abstract_t\">De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 2011; 115:575.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/77\" class=\"nounderline abstract_t\">De Oliveira GS Jr., Thran M. Dexamethasone: The wonder drug in perioperative medicine. J Clin Anesth 2017; 43:98.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/78\" class=\"nounderline abstract_t\">Toner AJ, Ganeshanathan V, Chan MT, et al. Safety of Perioperative Glucocorticoids in Elective Noncardiac Surgery: A Systematic Review and Meta-analysis. Anesthesiology 2017; 126:234.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/79\" class=\"nounderline abstract_t\">De Oliveira GS Jr, Castro-Alves LJ, Ahmad S, et al. Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg 2013; 116:58.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/80\" class=\"nounderline abstract_t\">Zhao X, Cao X, Li Q. Dexamethasone for the prevention of postoperative sore throat: a systematic review and meta-analysis. J Clin Anesth 2015; 27:45.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/81\" class=\"nounderline abstract_t\">Corcoran T, Kasza J, Short TG, et al. Intraoperative dexamethasone does not increase the risk of postoperative wound infection: a propensity score-matched post hoc analysis of the ENIGMA-II trial (EnDEX). Br J Anaesth 2017; 118:190.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/82\" class=\"nounderline abstract_t\">Jouguelet-Lacoste J, La Colla L, Schilling D, Chelly JE. The use of intravenous infusion or single dose of low-dose ketamine for postoperative analgesia: a review of the current literature. Pain Med 2015; 16:383.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/83\" class=\"nounderline abstract_t\">Avidan MS, Maybrier HR, Abdallah AB, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet 2017; 390:267.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthetic-management-for-enhanced-recovery-after-major-surgery-eras-in-adults/abstract/84\" class=\"nounderline abstract_t\">Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg 2017; 152:691.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 113724 Version 5.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H200683127\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1906261156\" id=\"outline-link-H1906261156\">INTRODUCTION</a></li><li><a href=\"#H911660903\" id=\"outline-link-H911660903\">DEFINITION OF ERAS</a></li><li><a href=\"#H3553091597\" id=\"outline-link-H3553091597\">PREOPERATIVE CONSIDERATIONS</a><ul><li><a href=\"#H2361859820\" id=\"outline-link-H2361859820\">Preanesthesia consultation</a></li><li><a href=\"#H3232169428\" id=\"outline-link-H3232169428\">Premedication</a></li></ul></li><li><a href=\"#H2526748191\" id=\"outline-link-H2526748191\">INTRAOPERATIVE ANESTHETIC MANAGEMENT</a><ul><li><a href=\"#H272906940\" id=\"outline-link-H272906940\">Induction of anesthesia</a></li><li><a href=\"#H1043323230\" id=\"outline-link-H1043323230\">Antibiotic prophylaxis</a></li><li><a href=\"#H1012725307\" id=\"outline-link-H1012725307\">Maintenance of anesthesia</a><ul><li><a href=\"#H2082250100\" id=\"outline-link-H2082250100\">- Inhalation versus total intravenous anesthesia</a></li><li><a href=\"#H2877574991\" id=\"outline-link-H2877574991\">- Opioids</a></li><li><a href=\"#H2313057756\" id=\"outline-link-H2313057756\">- Neuromuscular blocking agents</a></li><li><a href=\"#H3528502899\" id=\"outline-link-H3528502899\">- Nitrous oxide</a></li></ul></li><li><a href=\"#H2309437483\" id=\"outline-link-H2309437483\">Mechanical ventilation</a></li><li><a href=\"#H244926194\" id=\"outline-link-H244926194\">Fluid management</a></li><li><a href=\"#H497236349\" id=\"outline-link-H497236349\">Temperature control</a></li><li><a href=\"#H1125347342\" id=\"outline-link-H1125347342\">Glycemic control</a></li><li><a href=\"#H4078456404\" id=\"outline-link-H4078456404\">Antiemetic prophylaxis</a></li><li><a href=\"#H909429008\" id=\"outline-link-H909429008\">Pain prophylaxis</a></li></ul></li><li><a href=\"#H2165741456\" id=\"outline-link-H2165741456\">POSTOPERATIVE ANESTHETIC MANAGEMENT</a><ul><li><a href=\"#H1830785956\" id=\"outline-link-H1830785956\">Management of pain</a></li><li><a href=\"#H4243497461\" id=\"outline-link-H4243497461\">Management of nausea and vomiting</a></li></ul></li><li><a href=\"#H3965677478\" id=\"outline-link-H3965677478\">OUTCOMES</a></li><li><a href=\"#H200683127\" id=\"outline-link-H200683127\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ANEST/113724|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/115922\" class=\"graphic graphic_table\">- Example of anesthetic considerations for ERAS protocols</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-adult-patients-with-hypertension\" class=\"medical medical_review\">Anesthesia for adult patients with hypertension</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-laparoscopic-and-abdominal-robotic-surgery-in-adults\" class=\"medical medical_review\">Anesthesia for laparoscopic and abdominal robotic surgery in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-prophylaxis-for-prevention-of-surgical-site-infection-in-adults\" class=\"medical medical_review\">Antimicrobial prophylaxis for prevention of surgical site infection in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=awareness-with-recall-following-general-anesthesia\" class=\"medical medical_review\">Awareness with recall following general anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">Clinical use of neuromuscular blocking agents in anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enhanced-recovery-after-colorectal-surgery\" class=\"medical medical_review\">Enhanced recovery after colorectal surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enhanced-recovery-after-gynecologic-surgery-components-and-implementation\" class=\"medical medical_review\">Enhanced recovery after gynecologic surgery: Components and implementation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-anesthesia-induction\" class=\"medical medical_review\">General anesthesia: Induction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">General anesthesia: Intravenous induction agents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-anesthesia-maintenance-and-emergence\" class=\"medical medical_review\">General anesthesia: Maintenance and emergence</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses\" class=\"medical medical_review\">Inhalation anesthetic agents: Clinical effects and uses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery\" class=\"medical medical_review\">Inhalation anesthetic agents: Properties and delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intraoperative-fluid-management\" class=\"medical medical_review\">Intraoperative fluid management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-acute-perioperative-pain\" class=\"medical medical_review\">Management of acute perioperative pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-anastomotic-complications-of-colorectal-surgery\" class=\"medical medical_review\">Management of anastomotic complications of colorectal surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mechanical-ventilation-during-anesthesia-in-adults\" class=\"medical medical_review\">Mechanical ventilation during anesthesia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=monitoring-neuromuscular-blockade\" class=\"medical medical_review\">Monitoring neuromuscular blockade</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nerve-blocks-of-the-scalp-neck-and-trunk-techniques\" class=\"medical medical_review\">Nerve blocks of the scalp, neck, and trunk: Techniques</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-blood-glucose-in-adults-with-diabetes-mellitus\" class=\"medical medical_review\">Perioperative management of blood glucose in adults with diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-temperature-management\" class=\"medical medical_review\">Perioperative temperature management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-uses-of-intravenous-opioids-in-adults\" class=\"medical medical_review\">Perioperative uses of intravenous opioids in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=physiologic-and-pathophysiologic-consequences-of-mechanical-ventilation\" class=\"medical medical_review\">Physiologic and pathophysiologic consequences of mechanical ventilation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postoperative-nausea-and-vomiting\" class=\"medical medical_review\">Postoperative nausea and vomiting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preanesthesia-evaluation-for-noncardiac-surgery\" class=\"medical medical_review\">Preanesthesia evaluation for noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu\" class=\"medical medical_review\">Respiratory problems in the post-anesthesia care unit (PACU)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ventilator-induced-lung-injury\" class=\"medical medical_review\">Ventilator-induced lung injury</a></li></ul></div></div>","javascript":null}